Concepedia

Erik S. Pena

ES

Statistics

Publications

9

Citations

204

H-Index

9

Active since

2022

Affiliations

University of North Carolina at Chapel Hill(Current)

North Carolina State University

University of Georgia

Cleveland Clinic Florida

Vaccine & Gene Therapy Institute of Florida

Erik S. Pena is an author at University of North Carolina at Chapel Hill specializing in infectious diseases, vaccinology, and vaccine platforms.

ORCID

Publications per year

2022–2025

9

Publications

9

A predictive mechanistic model of drug release from surface eroding polymeric nanoparticles

Rebeca T. Stiepel, Erik S. Pena, Stephen A. Ehrenzeller et al. · Journal of Controlled Release · 2022 · 77 citations · Full text

, , +16

STING agonist-containing microparticles improve seasonal influenza vaccine efficacy and durability in ferrets over standard adjuvant

Matthew D. Gallovic, Robert D. Junkins, Adam Sandor et al. · Journal of Controlled Release · 2022 · 28 citations · Full text

, , +16

Supervised machine learning for predicting drug release from acetalated dextran nanofibers

Ryan N. Woodring, Elizabeth G. Graham-Gurysh, Tanvi Pulipaka et al. · Biomaterials Science · 2025 · 19 citations · Full text

, , +15

Development of an Intranasal Gel for the Delivery of a Broadly Acting Subunit Influenza Vaccine

Devika M. Varma, Cole J. Batty, Rebeca T. Stiepel et al. · ACS Biomaterials Science & Engineering · 2022 · 18 citations · Full text

, , +17

Comparative study of acetalated-dextran microparticle fabrication methods for a clinically translatable subunit-based influenza vaccine

Erik S. Pena, Cole J. Batty, Dylan A. Hendy et al. · International Journal of Pharmaceutics · 2024 · 16 citations · Full text

, , +16

1–5 of 9